Free Trial

Artelo Biosciences (ARTL) SEC Filings & 10K Form

Artelo Biosciences logo
$0.95 -0.02 (-1.67%)
Closing price 04/17/2025 03:53 PM Eastern
Extended Trading
$0.88 -0.07 (-7.53%)
As of 04/17/2025 05:48 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Recent Artelo Biosciences SEC Filings

DateFilerForm TypeView
03/20/2025
5:06 AM
Artelo Biosciences (Filer)
ARTELO BIOSCIENCES, INC. (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
03/03/2025
7:00 AM
Artelo Biosciences (Filer)
ARTELO BIOSCIENCES, INC. (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
12/23/2024
3:01 PM
Artelo Biosciences (Issuer)
ARTELO BIOSCIENCES, INC. (Issuer)
EMANUELE ROBERT MARTIN (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/23/2024
3:01 PM
Artelo Biosciences (Issuer)
ARTELO BIOSCIENCES, INC. (Issuer)
Reyes Gregory (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/23/2024
3:02 PM
Artelo Biosciences (Issuer)
ARTELO BIOSCIENCES, INC. (Issuer)
Blayney Douglas (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/23/2024
3:02 PM
Artelo Biosciences (Issuer)
ARTELO BIOSCIENCES, INC. (Issuer)
MATSUI CONNIE (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/23/2024
3:00 PM
Artelo Biosciences (Issuer)
ARTELO BIOSCIENCES, INC. (Issuer)
FAVORITO TAMARA A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/23/2024
3:01 PM
Artelo Biosciences (Issuer)
ARTELO BIOSCIENCES, INC. (Issuer)
Kelly Steven (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/20/2024
3:45 PM
Artelo Biosciences (Filer)
ARTELO BIOSCIENCES, INC. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/13/2024
7:06 AM
Artelo Biosciences (Filer)
ARTELO BIOSCIENCES, INC. (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
06/17/2024
4:27 PM
Artelo Biosciences (Subject)
ARTELO BIOSCIENCES, INC. (Subject)
Nasdaq Stock Market LLC (Filed by)
Form 25-NSE
05/13/2024
8:17 AM
Artelo Biosciences (Filer)
ARTELO BIOSCIENCES, INC. (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NASDAQ:ARTL) was last updated on 4/20/2025 by MarketBeat.com Staff
From Our Partners